High levels of S100B in cerebrospinal fluid (CSF) and peripheral blood have been observed in clinical research on Alzheimer's disease, stroke, traumatic brain injury, meningoencephalitis, mood disorders and schizophrenia [9-13]. The gene discussed is S100B; the disease is early-onset autosomal dominant Alzheimer disease.